by nikki mann | Jan 29, 2026 | News
Last week, the Milner Institute welcomed more than 45 of its affiliated companies to a business-to-business networking event on the Cambridge Biomedical Campus. The event brought together start-ups from the Milner Bio-incubator and beyond, biotech, services and CRO...
by nikki mann | Jan 26, 2026 | News
We’re delighted that our Executive Director, Professor Cathy Tralau-Stewart, has continued her thought leadership work with Drug Discovery World, with a timely article on “The role of universities and industry in driving translation of therapeutics: the need for a new...
by nikki mann | Nov 27, 2025 | News
We are thrilled to announce that the Functional Genomics Screening Laboratory (FGSL) has been awarded an OBN Award in the Most Impactful Industry Collaboration category. This recognises the pioneering work taking place in the FGSL — a collaboration between the Milner...
by nikki mann | Nov 12, 2025 | News
Milner Executive Director Cathy Tralau-Stewart was delighted to join Drug Discovery World (DDW) at their 2025 Symposium this month, which brought together leaders from drug discovery, academia, and biotech to explore how innovation can move more effectively from...
by nikki mann | Nov 5, 2025 | News
Earlier this week, we were delighted to team up with Cambridge Network to host an event at the West Hub in Cambridge. The event provided an overview of the Institute’s unique translational ecosystem, and Cambridge Network members gathered to learn more about the ways...
by nikki mann | Sep 29, 2025 | News
The Milner Institute was proud to take part in BioCentury’s Grand Rounds Europe conference in Cambridge this month. Over three days of keynotes, fireside chats, panel discussions and networking sessions, Grand Rounds fostered meaningful dialogue, inspired new ideas,...
by nikki mann | Sep 22, 2025 | News
We are delighted to announce that Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. The Milner team works closely with this unique grouping of pharma companies to advance research towards new therapeutics across multiple disease...
by nikki mann | Sep 15, 2025 | News
Last week, we were delighted to welcome Pippa Heylings MP, Charlotte Cane MP and Councillor Olaf Hauk to the Milner Therapeutics Institute. The visit provided an opportunity to showcase our mission and impact, including our pioneering research, collaborations with...
by nikki mann | Sep 8, 2025 | News
We are delighted to share that Dr Namshik Han, Head of AI and Computational Research at the Milner Therapeutics Institute, has begun a new role as Professor at Yonsei University in Seoul, South Korea. Namshik will divide his time between Yonsei University and the...
by nikki mann | Sep 8, 2025 | News
We are delighted to share that the Milner Therapeutics Institute has been announced as a finalist for a 2025 OBN Award in the category of Most Impactful Industry Collaboration! We have been recognised for the Functional Genomics Screening Laboratory (FGSL), a...
